The Pharmacoeconomics of Vaccines: Advancing Cost-Effectiveness and Access in Global Immunization Strategies

Edited by:

Wenxi Tang, PhD, China Pharmaceutical University, China

Submission Status: Open | Submission Deadline: 15 January 2026

Health Economics Review is calling for submissions to our Collection on The Pharmacoeconomics of Vaccines.

Scope and Submissions:

   Cost-effectiveness analyses (CEA) and budget impact models of new and existing vaccines
   Pricing strategies and market dynamics affecting vaccine affordability and accessibility
   Economic evaluations of novel immunization technologies and delivery systems
   The role of Pharmacoeconomics in vaccine policy-making and reimbursement decisions
   Societal and indirect cost benefits of immunization programs
   Economic modeling approaches to assess vaccine interventions in different healthcare settings
   Comparative analyses of vaccine funding strategies in low-, middle-, and high-income countries
   Value-based assessment of a vaccine
   Other challenges (e.g. in regulatory science, expanding the National Immunization Program, adjuvant technologies, Real World Evidence bridging clinical trials and policy, hesitancy) related to vaccine (e.g. combined vaccine, polyvalent vaccine).

Image credit: © alexandra / stock.adobe.com

New Content Item This Collection supports and amplifies research related to SDG 3: Good Health & Well-Being.

Submit to Collection

Meet the Guest Editors

Back to top

Wenxi Tang, PhD, China Pharmaceutical University, China

Dr. Tang received her BEs degree in Economics from China Pharmaceutical University in 2008 and a PhD in Social Medicine and Health Management from Huazhong University of Science and Technology in 2015. She completed postdoctoral research in Pharmaceutical Policy and Science at the University of Arizona in 2017-2018. As a PI, Dr Tang has received six national fundings from National Natural Science Foundation of China, Ministry of Science and Technology and Bill & Melinda Gates foundation. Her grants covered topics in integrated care, regulatory science of vaccines and capability development in primary care. Tang has published over 90 peer-reviewed articles in journals since 2015. Her work on prescription drug pricing was featured in a 2018 US news report. She has been awarded Jiangsu Outstanding Youth Talent in Social Science in 2019 and been recognized as part of the Jiangsu "333 High-Level Talent Cultivation Project" in 2021. Her course, "Pharmaceutical Value and Economic Evaluation," is recognized as a National Outstanding Online Course. Dr. Tang has also contributed to the national textbook Health Technology Assessment (2nd Edition).

There are currently no articles in this collection.

Submission Guidelines

Back to top

This Collection welcomes submission of original research articles. Should you wish to submit a different article type, please read our submission guidelines to confirm that type is accepted by the journal.

Articles for this Collection should be submitted via our submission system, Snapp. Please, select the appropriate Collection title “The Pharmacoeconomics of Vaccines: Advancing Cost-Effectiveness and Access in Global Immunization Strategies" under the “Details” tab during the submission stage.

Articles will undergo the journal’s standard peer-review process and are subject to all the journal’s standard policies. Articles will be added to the Collection as they are published.

The Editors have no competing interests with the submissions which they handle through the peer-review process. The peer-review of any submissions for which the Editors have competing interests is handled by another Editorial Board Member who has no competing interests.